July 2013 Issue Table Of Contents
Source: Life Science Leader

From The Editor
Ask The Board
Capitol Perspectives
Companies To Watch
Outsourcing Insights
Bio Innovation notes
Feature
- J&J’s Approach To Drug Discovery And Breakthrough Therapy
- Aptalis — The “Three Ms” Of Specialty Pharma
Inside The Industry
- Biosimilars In Emerging Markets
- Generic Drugs: An Impending Drought?
- Perils And Challenges Of Building A Biotech In Kentucky
- Norwegian Biotech Faces The Funding Gap
- Shifting Recruitment Patterns In The Pharma Industry
- New Trends In Pharma/Bio Executive Compensation
- Serialization Approval Possible By August
- GDUFA Sheds New Light On Industry’s Common Ground
Industry Leader
This website uses cookies to ensure you get the best experience on our website. Learn more